{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:40:55Z","timestamp":1792669255779,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12873-w","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:06:57Z","timestamp":1792667217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulation of the NAMPT\/SIRT axis in HeLa cells exposed to adipose-derived mesenchymal stem cell-conditioned medium"],"prefix":"10.1007","volume":"53","author":[{"given":"Mona","family":"Roozbehani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Vafaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Keyvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoo","family":"Tasbihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Masoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"12873_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"12873_CR2","first-page":"169","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A et al (2019) Cervical cancer Lancet 393:169\u2013182","journal-title":"Cervical cancer Lancet"},{"key":"12873_CR3","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L et al (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8:e191\u2013e203","journal-title":"Lancet Glob Health"},{"key":"12873_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/ijgc-2022-003703","volume":"33","author":"D Viveros-Carreno","year":"2023","unstructured":"Viveros-Carreno D, Fernandes A, Pareja R (2023) Updates on cervical cancer prevention. Int J Gynecol Cancer 33:394\u2013402","journal-title":"Int J Gynecol Cancer"},{"key":"12873_CR5","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/jpm12122031","volume":"12","author":"A Chen","year":"2022","unstructured":"Chen A, Li X, Chen S (2022) Prediction of cervical cancer outcome by identifying and validating a NAD+ metabolism-derived gene signature. J Pers Med 12:2031","journal-title":"J Pers Med"},{"key":"12873_CR6","doi-asserted-by":"crossref","unstructured":"Lu X (2025) NAD+ metabolism reprogramming drives SIRT1-dependent PD-L1 expression and nuclear localization in cervical cancer. Adv Sci, : p. e2412109","DOI":"10.1002\/advs.202412109"},{"key":"12873_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s11051-025-06410-2","volume":"27","author":"R Fallahi","year":"2025","unstructured":"Fallahi R, Shafaghat Z, Minaeian S et al (2025) Novel insights into possible ZnO nanoparticle-induced changes in key metabolic enzymes in HeLa cervical cancer cell line. J Nanopart Res 27:234","journal-title":"J Nanopart Res"},{"key":"12873_CR8","doi-asserted-by":"publisher","first-page":"e99206","DOI":"10.5812\/gct.99206","volume":"7","author":"S Ghorbani","year":"2020","unstructured":"Ghorbani S, Maleki M (2020) Inhibition of cervical cancer cell line HeLa by human Wharton\u2019s jelly stem cells through induction of apoptosis. Gene Cell Tissue 7:e99206","journal-title":"Gene Cell Tissue"},{"key":"12873_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2443.2010.01460.x","volume":"16","author":"Y Li","year":"2011","unstructured":"Li Y, Matsumori H, Nakayama Y et al (2011) SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells 16:34\u201345","journal-title":"Genes Cells"},{"key":"12873_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.15296\/ijwhr.2020.51","volume":"8","author":"F Rahmatizadeh","year":"2020","unstructured":"Rahmatizadeh F, Pashaei-Asl F, Dehcheshmeh MM et al (2020) Reduction in the viability of human cervical cancer HeLa cell line via indirect co-culture with amniotic fluid-derived mesenchymal stem cells. Int J Womens Health Reprod Sci 8:319\u2013327","journal-title":"Int J Womens Health Reprod Sci"},{"key":"12873_CR11","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.1007\/s13277-015-3300-y","volume":"36","author":"S Singh","year":"2015","unstructured":"Singh S, Kumar PU, Thakur S et al (2015) Expression\/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells. Tumour Biol 36:6159\u20136171","journal-title":"Tumour Biol"},{"key":"12873_CR12","first-page":"4821","volume":"37","author":"M Vora","year":"2017","unstructured":"Vora M, Alattia LA, Ansari J et al (2017) Nicotinamide phosphoribosyl transferase a reliable marker of progression in cervical dysplasia. Anticancer Res 37:4821\u20134825","journal-title":"Anticancer Res"},{"key":"12873_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells: The International Society for Cellular Therapy position statement. Cytotherapy 8:315\u2013317","journal-title":"Cytotherapy"},{"key":"12873_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcyt.2014.12.008","volume":"17","author":"J Galipeau","year":"2015","unstructured":"Galipeau J, Krampera M (2015) The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria. Cytotherapy 17:125\u2013127 https:\/\/doi.org\/10.1016\/j.jcyt.2014.12.008","journal-title":"Cytotherapy"},{"key":"12873_CR15","doi-asserted-by":"publisher","first-page":"e0162332","DOI":"10.1371\/journal.pone.0162332","volume":"11","author":"O El Atat","year":"2016","unstructured":"El Atat O, Antonios D, Hilal G et al (2016) An evaluation of the stemness, paracrine, and tumorigenic characteristics of highly expanded, minimally passaged adipose-derived stem cells. PLoS ONE 11:e0162332","journal-title":"PLoS ONE"},{"key":"12873_CR16","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/pharmaceutics14051112","volume":"14","author":"L Olmedo-Moreno","year":"2022","unstructured":"Olmedo-Moreno L, Aguilera Y, Balina-Sanchez C et al (2022) Heterogeneity of in vitro expanded mesenchymal stromal cells and strategies to improve their therapeutic actions. Pharmaceutics 14:1112","journal-title":"Pharmaceutics"},{"key":"12873_CR17","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/ten.teb.2023.0048","volume":"29","author":"JA Ramirez Idarraga","year":"2023","unstructured":"Ramirez Idarraga JA, Restrepo Munera LM (2023) Mesenchymal stem cells: their role in the tumor microenvironment. Tissue Eng Part B Rev 29:681\u2013691","journal-title":"Tissue Eng Part B Rev"},{"key":"12873_CR18","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","volume":"13","author":"PA Zuk","year":"2002","unstructured":"Zuk PA, Zhu M, Ashjian P et al (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279\u20134295","journal-title":"Mol Biol Cell"},{"key":"12873_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fbioe.2020.00043","volume":"8","author":"A Hmadcha","year":"2020","unstructured":"Hmadcha A, Martin-Montalvo A, Gauthier BR et al (2020) Therapeutic potential of mesenchymal stem cells for cancer therapy. Front Bioeng Biotechnol 8:43","journal-title":"Front Bioeng Biotechnol"},{"key":"12873_CR20","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.1038\/s41598-020-69907-x","volume":"10","author":"R Castro-Oropeza","year":"2020","unstructured":"Castro-Oropeza R, Vazquez-Santillan K, Diaz-Gastelum C et al (2020) Adipose-derived mesenchymal stem cells promote the malignant phenotype of cervical cancer. Sci Rep 10:14205","journal-title":"Sci Rep"},{"key":"12873_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.7150\/ijms.41354","volume":"17","author":"CS Byun","year":"2020","unstructured":"Byun CS, Hwang S, Woo SH et al (2020) Adipose tissue-derived mesenchymal stem cells suppress growth of Huh7 hepatocellular carcinoma cells via interferon-beta-mediated JAK\/STAT1 pathway in vitro. Int J Med Sci 17:609\u2013619","journal-title":"Int J Med Sci"},{"key":"12873_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.canlet.2018.10.017","volume":"440","author":"PY Jung","year":"2019","unstructured":"Jung PY, Ryu H, Rhee KJ et al (2019) Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-beta and TRAIL and suppress the growth of H460 human lung cancer cells. Cancer Lett 440:202\u2013210","journal-title":"Cancer Lett"},{"key":"12873_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.canlet.2014.06.018","volume":"352","author":"H Ryu","year":"2014","unstructured":"Ryu H, Oh JE, Rhee KJ et al (2014) Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-B and suppress the growth of MCF-7 human breast cancer cells. Cancer Lett 352:220\u2013227","journal-title":"Cancer Lett"},{"key":"12873_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10616-024-00652-z","volume":"76","author":"M Dorfaki","year":"2024","unstructured":"Dorfaki M, Faraji F, Roozbehani M et al (2024) Conditioned media from human adipose tissue-derived mesenchymal stem cells: potential effect on peripheral blood mononuclear cells in co-culture with HeLa cell line. Cytotechnology 76:761\u2013775","journal-title":"Cytotechnology"},{"key":"12873_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4274\/tji.galenos.2024.35219","volume":"12","author":"M Dorfaki","year":"2024","unstructured":"Dorfaki M, Ghatrehsamani M, Arab FL et al (2024) Effects of adipose-tissue derived mesenchymal stem cells on PBMCs in co-culture with HeLa cell line. Turk J Immunol 12:19\u201327","journal-title":"Turk J Immunol"},{"key":"12873_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jcyt.2013.11.008","volume":"16","author":"J Cuerquis","year":"2014","unstructured":"Cuerquis J, Romieu-Mourez R, Francois M et al (2014) Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-gamma and tumor necrosis factor-alpha stimulation. Cytotherapy 16:191\u2013202","journal-title":"Cytotherapy"},{"key":"12873_CR27","doi-asserted-by":"publisher","first-page":"101957","DOI":"10.1016\/j.trim.2023.101957","volume":"81","author":"Z Shafeghat","year":"2023","unstructured":"Shafeghat Z, Dorfaki M, Dehrouyeh S et al (2023) Mesenchymal stem cell-derived exosomes for managing graft-versus-host disease: An updated view. Transpl Immunol 81:101957","journal-title":"Transpl Immunol"},{"key":"12873_CR28","doi-asserted-by":"publisher","first-page":"106189","DOI":"10.1016\/j.biocel.2022.106189","volume":"145","author":"M Gasparrini","year":"2022","unstructured":"Gasparrini M, Audrito V (2022) NAMPT: a critical driver and therapeutic target for cancer. Int J Biochem Cell Biol 145:106189","journal-title":"Int J Biochem Cell Biol"},{"key":"12873_CR29","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/cancers14092059","volume":"14","author":"TC Lin","year":"2022","unstructured":"Lin TC (2022) Updated functional roles of NAMPT in carcinogenesis and therapeutic niches. Cancers (Basel) 14:2059","journal-title":"Cancers (Basel)"},{"key":"12873_CR30","doi-asserted-by":"publisher","first-page":"1480617","DOI":"10.3389\/fmolb.2024.1480617","volume":"11","author":"A Peng","year":"2024","unstructured":"Peng A, Li J, Xing J, Yao Y et al (2024) The function of nicotinamide phosphoribosyl transferase (NAMPT) and its role in diseases. Front Mol Biosci 11:1480617. https:\/\/doi.org\/10.3389\/fmolb.2024.1480617. PMID: 39513038; PMCID: PMC11540786","journal-title":"Front Mol Biosci"},{"key":"12873_CR31","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1158\/1078-0432.CCR-17-2575","volume":"24","author":"A Lucena-Cacace","year":"2018","unstructured":"Lucena-Cacace A, Otero-Albiol D, Jimenez-Garcia MP et al (2018) NAMPT is a potent oncogene in colon cancer progression that modulates cancer stem cell properties and resistance to therapy through Sirt1 and PARP. Clin Cancer Res 24:1202\u20131215","journal-title":"Clin Cancer Res"},{"key":"12873_CR32","doi-asserted-by":"publisher","first-page":"970553","DOI":"10.3389\/fphar.2022.970553","volume":"13","author":"Y Wei","year":"2022","unstructured":"Wei Y, Xiang H, Zhang W (2022) Review of various NAMPT inhibitors for the treatment of cancer. Front Pharmacol 13:970553","journal-title":"Front Pharmacol"},{"key":"12873_CR33","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1080\/15384101.2019.1634953","volume":"18","author":"LF Costa-Machado","year":"2019","unstructured":"Costa-Machado LF, Fernandez-Marcos PJ (2019) The sirtuin family in cancer. Cell Cycle 18:2164\u20132196","journal-title":"Cell Cycle"},{"key":"12873_CR34","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.arr.2019.100961","volume":"55","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang J, Hong T et al (2019) SIRT2: controversy and multiple roles in disease and physiology. Ageing Res Rev 55:100961","journal-title":"Ageing Res Rev"},{"key":"12873_CR35","doi-asserted-by":"publisher","first-page":"1384928","DOI":"10.3389\/fonc.2024.1384928","volume":"14","author":"L Yu","year":"2024","unstructured":"Yu L (2024) The dual role of sirtuins in cancer: biological functions and implications. Front Oncol 14:1384928","journal-title":"Front Oncol"},{"key":"12873_CR36","doi-asserted-by":"crossref","unstructured":"Chen J, Chen H, Pan L (2021) SIRT1 and gynecological malignancies (Review). Oncol Rep. ;45(4):43. doi: 10.3892\/or.2021.7994. Epub 2021 Mar 2. PMID: 33649834; PMCID: PMC7934219","DOI":"10.3892\/or.2021.7994"},{"key":"12873_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.humpath.2016.09.019","volume":"59","author":"A Velez-Perez","year":"2017","unstructured":"Velez-Perez A, Wang XI, Li M, Zhang S (2017) SIRT1 overexpression in cervical squamous intraepithelial lesions and invasive squamous cell carcinoma. Hum Pathol 59:102\u2013107","journal-title":"Hum Pathol"},{"key":"12873_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fphar.2019.00038","volume":"10","author":"V Carafa","year":"2019","unstructured":"Carafa V, Altucci L, Nebbioso A (2019) Dual tumor-suppressor and tumor-promoter action of sirtuins in determining malignant phenotype. Front Pharmacol 10:38","journal-title":"Front Pharmacol"},{"issue":"2","key":"12873_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.7150\/ijbs.5.147","volume":"5","author":"CX Deng","year":"2009","unstructured":"Deng CX (2009) SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 5(2):147\u2013152","journal-title":"Int J Biol Sci"},{"key":"12873_CR40","doi-asserted-by":"publisher","unstructured":"Vaziri H, Dessain SK, Ng Eaton E et al (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. ;107(2):149\u2009\u2013\u200959. https:\/\/doi.org\/10.1016\/s0092-8674(01)00527-x. PMID: 11672523","DOI":"10.1016\/s0092-8674(01)00527-x"},{"issue":"1","key":"12873_CR41","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12885-018-4710-1","volume":"18","author":"T Kozako","year":"2018","unstructured":"Kozako T, Mellini P, Ohsugi T et al (2018) Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines. BMC Cancer 18(1):791. https:\/\/doi.org\/10.1186\/s12885-018-4710-1","journal-title":"BMC Cancer"},{"key":"12873_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41421-022-00398-y","volume":"8","author":"H Zu","year":"2022","unstructured":"Zu H, Li C, Dai C et al (2022) SIRT2 functions as a histone delactylase and inhibits the proliferation and migration of neuroblastoma cells. Cell Discov 8:54","journal-title":"Cell Discov"},{"key":"12873_CR43","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00337.2023","volume":"327","author":"J Guo","year":"2024","unstructured":"Guo J, Yuan Z, Wang R (2024) Zn2\u2009+\u2009improves sepsis-induced acute kidney injury by up-regulating SIRT7-mediated Parkin acetylation. Am J Physiol Ren Physiol 327:F1\u2013F13","journal-title":"Am J Physiol Ren Physiol"},{"key":"12873_CR44","doi-asserted-by":"publisher","first-page":"e2409269121","DOI":"10.1073\/pnas.2409269121","volume":"121","author":"P Kumari","year":"2024","unstructured":"Kumari P (2024) SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF. Proc Natl Acad Sci U S A 121:e2409269121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12873_CR45","doi-asserted-by":"publisher","first-page":"101461","DOI":"10.1016\/j.isci.2020.101461","volume":"23","author":"X Liu","year":"2020","unstructured":"Liu X, Li C, Li Q et al (2020) SIRT7 facilitates CENP-A nucleosome assembly and suppresses intestinal tumorigenesis. iScience 23:101461","journal-title":"iScience"},{"key":"12873_CR46","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1111\/febs.14259","volume":"284","author":"Y Mo","year":"2017","unstructured":"Mo Y, Lin R, Liu P et al (2017) SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes. FEBS J 284:3619\u20133636","journal-title":"FEBS J"},{"key":"12873_CR47","doi-asserted-by":"publisher","DOI":"10.2478\/fco-2024-0014","author":"S Jannati","year":"2025","unstructured":"Jannati S, Roozbehani M, Khoshmirsafa M et al (2025) Effects of Lactobacillus acidophilus and Lactobacillus plantarum on Survival and Proliferation of Breast Cancer Cell Line MCF-7. Forum Clin Oncol ahead print. https:\/\/doi.org\/10.2478\/fco-2024-0014","journal-title":"Forum Clin Oncol ahead print"},{"issue":"13","key":"12873_CR48","doi-asserted-by":"publisher","first-page":"12609","DOI":"10.18632\/aging.103606","volume":"12","author":"N Alessio","year":"2020","unstructured":"Alessio N, Acar MB, Demirsoy IH et al (2020) Obesity is associated with senescence of mesenchymal stromal cells derived from bone marrow, subcutaneous and visceral fat of young mice. Aging 12(13):12609\u201312621. https:\/\/doi.org\/10.18632\/aging.103606","journal-title":"Aging"},{"issue":"11","key":"12873_CR49","doi-asserted-by":"publisher","first-page":"8996","DOI":"10.1002\/jcp.26845","volume":"233","author":"N Alessio","year":"2018","unstructured":"Alessio N, Pipino C, Mandatori D et al (2018) Mesenchymal stromal cells from amniotic fluid are less prone to senescence compared to those obtained from bone marrow: An in vitro study. J Cell Physiol 233(11):8996\u20139006. https:\/\/doi.org\/10.1002\/jcp.26845","journal-title":"J Cell Physiol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12873-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12873-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12873-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:06:59Z","timestamp":1792667219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12873-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12873"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12873-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"3 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The broader research project was approved by the Ethics Committee of Iran University of Medical Sciences (IR.IUMS.REC.1403.409). The present in vitro study used HeLa cells and a cryopreserved, previously validated AD-MSC stock. Adipose tissue used to establish the original MSC stock had been collected with written informed consent in the earlier study. Not applicable to the present in vitro work using a cell line and cryopreserved, previously validated MSC stock.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No identifiable human participant data are included.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used ChatGPT (OpenAI) for language editing, enhance conciseness, reduce word count and graphical abstract assistance. All outputs were reviewed by the authors, who remain responsible for the scientific content and conclusions.","order":3,"name":"Ethics","label":"Declaration of generative AI and AI-assisted editing disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1780"}}